Bingzi Dong

Qingdao University — China

Medicine · Health Sciences

19h-index1.6kcitations90works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gout, Hyperuricemia, Uric Acid(12), Liver Disease Diagnosis and Treatment(11), Cancer-related molecular mechanisms research(8), Cholangiocarcinoma and Gallbladder Cancer Studies(8), Diabetes Treatment and Management(6)

Publications89 total

Treatment-induced neuropathy of diabetes overlapping with chronic inflammatory demyelinating polyradiculoneuropathy after rapid glycemic correction: a case report
Frontiers in Endocrinology·2025· 1 citedOpen Access
Review: Progress of the NLRP3 inflammasome in tumours and perspectives for cholangiocarcinoma
Cell Communication and Signaling·2025· 3 citedOpen Access
LncRNA938/ TAF9/TTK axis promotes EMT and serves as a therapeutic target in hepatoblastoma
Journal of Translational Medicine·2025Open Access
Radiomics-based machine-learning method to predict extrahepatic metastasis in hepatocellular carcinoma after hepatectomy: a multicenter study
Scientific Reports·2025Open Access
Finerenone in Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Efficacy and Safety
Diabetes/Metabolism Research and Reviews·2025· 1 cited
Association between thyroid function and type 2 diabetes mellitus based on the NHANES and Mendelian randomization study
HORMONES·2025· 3 cited
Association between fetal exposure to the Chinese famine and cognitive decline in adulthood: a retrospective cohort study
Frontiers in Nutrition·2025Open Access
Editorial: The prevention and treatment of diabetic osteoporosis
Frontiers in Endocrinology·2025Open Access
[Research progresses on phosphate homeostasis and phosphate toxicity in type 2 diabetes mellitus and its complications].
PubMed·2025
Unraveling the link between metabolic dysfunction-associated steatotic liver disease and osteoporosis: a bridging function of gut microbiota
Frontiers in Endocrinology·2025· 1 citedOpen Access
Comparing Efficacy of Chiglitazar, Pioglitazone, and Semaglutide in Type 2 Diabetes: A Retrospective Study
Diabetes Therapy·2025· 1 citedOpen Access
Evaluation of the Regulatory Effect of the Pan-PPAR Agonist Chiglitazar on the Dawn Phenomenon
Diabetes Therapy·2025· 4 citedOpen Access
Associations of the ALDH2 rs671 polymorphism and alcohol intake with early-onset gout in a Chinese male cohort
Joint Bone Spine·2025· 1 cited
A Study of Risk Factors for Surgical Site Infections and Direct Economic Losses in Clean Orthopedic Surgery
Surgical Infections·2025· 1 cited
Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC
The Journal of Clinical Endocrinology & Metabolism·2025
An evaluation study of direct economic losses from surgical site infections in adults: structural equation modeling
Frontiers in Public Health·2025· 1 citedOpen Access
Diabetes drug crosses over: Metformin emerges as novel therapeutic option for hematologic malignancies
The Innovation Medicine·2025Open Access
Analysis of risk factors for surgical site infection in spinal surgery patients and study of direct economic losses
BMC Musculoskeletal Disorders·2024· 10 citedOpen Access
Association between sarcopenia and the foot-ankle function in type 2 diabetic foot ulcer
UNC Libraries·2024Open Access
Association between sarcopenia and the foot-ankle function in type 2 diabetic foot ulcer
Diabetology & Metabolic Syndrome·2024· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Yangang Wang(17), Chengzhan Zhu(10), Yajing Huang(10), Wenshan Lv(9), Jingwei Chi(7), Yue Zhou(6), Yixiu Wang(6), Itsuro Endo(6), Toshio Matsumoto(6), Lili Xu(5), Yuwei Xie(5), Masahiro Abe(5), Seiji Fukumoto(5), Yangang Wang(5), Weijie Xue(4), Yukiyo Ohnishi(4), Takeshi Kondo(4), Ying Chen(4), Chuanfeng Liu(4), Lili Xu(4)